Actos and Cefadroxil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actos (pioglitazone hydrochloride) and Cefadroxil (cefadroxil/cefadroxil hemihydrate). Common drug interactions include knee deformity among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Actos and Cefadroxil. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.

What is Cefadroxil?

Cefadroxil has active ingredients of cefadroxil/cefadroxil hemihydrate. It is often used in acne. eHealthMe is studying from 1,897 Cefadroxil users. Check the latest studies of Cefadroxil.

On Jul, 17, 2026

25 people who take Actos and Cefadroxil together, and have interactions are studied.

What are the common drug interactions of Actos and Cefadroxil, by gender? *:

female:

Knee deformity (functional disability of knee)
Medical device complication
Meniscal degeneration (loss of function in a crescent-shaped piece of cartilage between the femur and the tibia)
Meniscus lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia)
Multiple injuries
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Myocarditis (inflammation of heart muscle myocardium)
Nausea (feeling of having an urge to vomit)
Neck pain
Nephrogenic anaemia (anaemia due to kidney disease)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Gait disturbance
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Pain
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Cholangitis (infection of the bile duct)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the common drug interactions of Actos and Cefadroxil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Bone pain
Chronic kidney disease
Drug resistance (reduction in effectiveness of a drug)
Emotional distress
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Gait disturbance
Pain

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Diabetic end stage renal disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)

60+:

Chronic kidney disease
Deformity (disfigurement)
Scar
Skin lesion
Abdominal pain
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Diastolic dysfunction
Dyspnoea (difficult or laboured respiration)
Heart rate decreased
Heart rate irregular

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 48.00%
Pain: 9 people, 36.00%
High Blood Cholesterol: 8 people, 32.00%
High Blood Pressure: 8 people, 32.00%
Inflammation: 7 people, 28.00%
Type 2 Diabetes: 6 people, 24.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
Hypersensitivity: 5 people, 20.00%
Neuropathy Peripheral (surface nerve damage): 4 people, 16.00%
Swelling: 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Actos and Cefadroxil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously